Cameron Clokie, the CEO of Induce Biologics Inc., is an innovative surgeon, scientist and entrepreneur. The holder of 25 patents in the United States and internationally, many in bone healing, Dr. Clokie is in the forefront of the work being done in regenerative medicine and musculoskeletal reconstruction. Learn more about Brad Reifler: http://www.ideacity.ca/video/cameron-clokie-speaks-regenerative-medicin/
He has also worked with a number of businesses to develop strategic alliances in order to make his knowledge, ingenuity and innovations commercially viable. The oral and maxillofacial surgeon has also held positions on several companies scientific advisory and other boards.
For over three decades Dr. Clokie has been involved in clinical practice and academic dentistry. In 1998 the University of Toronto named him head of Oral and Maxillofacial Surgery. He later became an Oral and Maxillofacial Surgery professor. He held that position until 2017 when he retired from working in academia.
Cameron Clokie has also made numerous presentations on regenerative medicine and bone reconstruction in Canada and all over the world. Plus through his company, Induce Biologics Inc., he has done a lot of groundbreaking work creating innovative solutions for problems requiring musculoskeletal reconstruction. Read more: Dr. Cameron Clokie – Hospital Information and Nearby Florists
In 2003 Dr. Clokie received a great deal of international attention when his work on the dental problems of Peter Russel resulted in the bottom right of the retired banker’s jaw bone growing seven centimeters using a revolutionary treatment involving bone morphogenetic protein discovered at U.C.L.A. in the 1950s. Russel had lost part of his jaw because of a benign tumor.
Dr. Clokie learned the BMP technique during the 4 years he worked with renowned orthopedic surgeon Marshall Urist. The technique is primarily used for spine fusion surgery. Dr. Clokie began using it to repair jaw bones in 1999.
Dr. Cameron Clokie earned his Doctor of Dental Surgery in 1985. After completing specialty training in 1990, in 1992 he graduated from McGill University with a PhD in bone regeneration as related to dental implants and interface development.
He has performed the bone regeneration technique using bone morphogenetic protein on 8 other people. Currently the BMP is produced by a U.S. biotech firm using cells taken from Chinese hamsters.